Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
0.635
-0.015 (-2.25%)
Dec 20, 2024, 4:00 PM EST - Market closed
Karyopharm Therapeutics Employees
Karyopharm Therapeutics had 325 employees as of December 31, 2023. The number of employees decreased by 60 or -15.58% compared to the previous year.
Employees
325
Change (1Y)
-60
Growth (1Y)
-15.58%
Revenue / Employee
$456,745
Profits / Employee
-$269,166
Market Cap
79.57M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
23andMe Holding Co. | 582 |
bluebird bio | 375 |
EDAP TMS | 307 |
Rani Therapeutics Holdings | 140 |
Adlai Nortye | 127 |
Quince Therapeutics | 32 |
Entera Bio | 18 |
Tiziana Life Sciences | 9 |
KPTI News
- 12 days ago - Karyopharm Announces the Appointment of Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications - PRNewsWire
- 18 days ago - Karyopharm Therapeutics Provides Endometrial Cancer Program Update - PRNewsWire
- 19 days ago - Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 26 days ago - Karyopharm to Participate at the Piper Sandler 36th Annual Healthcare Conference - PRNewsWire
- 4 weeks ago - Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer - PRNewsWire
- 4 weeks ago - Karyopharm to Present Selinexor Data at the 66th American Society of Hematology Annual Meeting and Exposition - PRNewsWire
- 6 weeks ago - Karyopharm Therapeutics Inc. (KPTI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Antengene to Present Results from Two Late-Stage Studies of Selinexor Signaling Potential Clinical Breakthrough at ASH 2024 - PRNewsWire